- Formulation re: Other
- Proven active form
- Brand IP Statement(s) re: (c), (TM), (SM)
- Sublinthion
Patented protection system
- Formula re: Contains
- Patented, reduced oral glutathione for vital support
- Formulation re: Other
- 230% greater blood ratios
- Formulation re: Other
- Proven stability
230% improvement
- FDA Statement of Identity
- Dietary Supplement
- Formulation re: Vegetarian/Vegan
- Vegan
- Formulation re: Does NOT Contain
- Non-GMO
- FDA Disclaimer Statement
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- General Statements: All Other Content
- Product of France
- Brand IP Statement(s) re: (c), (TM), (SM)
- French patent #FR2972327
- Formulation re: Other
- In a published human study, Clinical Glutathione with Sublinthion reported a 230% improvement in healthy glutathione ratios compared to unprotected glutathione.
- General Statements: All Other Content
- Blood ratios of active glutathione to oxidized glutathione between day 1 and day 21 after supplementation.
Blood GSH/GSSG ratio compared to unprotected glutathione
- Formulation re: Does NOT Contain
- No sugar, salt, wheat, gluten, corn, soy, dairy products, artificial coloring, or artificial preservatives.
- Suggested/Recommended/Usage/Directions
- Recommendations: Take 2 tablets daily. One tablet in a.m. and one tablet in the p.m., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.
- Precautions re: Pregnant or Nursing or Prescription Medications
- If pregnant or nursing, consult a healthcare practitioner before using.